Ben Lamm's startup, Colossal Biosciences, has raised $200 million, valuing the company at $10.2 billion. This funding round, led by TWG Global, will be used to advance genetic engineering, expand the company's software and hardware solutions, and potentially de-extinct the woolly mammoth, Tasmanian tiger, and dodo bird
Hosted on Acast. See acast.com/privacy for more information.
